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Abstract 
Diabetes mellitus with its high prevalence and related hygienic problems is one of the most important 
worldwide burdens that can also cause mental and psychological side effects. The disease complications, chronic 
progress, treatment costs and social problems are among the issues that can affect the patients’ cognitive function 
and cause depression and sleep disorders. Failure to diagnose and treatment of such issues causes a poor prognosis 
and increases the risk of death. High prevalence of sleep disorders in diabetic adults and its association with 
depression and glucose metabolism encouraged us to conduct a study to compare the frequency of depression and 
sleep disorders in type-2 diabetic patients with non-diabetics. Methodology In a prospective case-control study 
design, considering the inclusion and exclusion criteria, 64 diabetic patients from 22 Bahman Hospital and 86 non-
diabetic individuals as the matched group, were enrolled in the study during the years 2013 to 2014. To gather the 
data, Pittsburg sleep quality index and Hamilton depression rating scale was used. Results Sleep quality disorders 
and depression are more common in diabetic patients. In diabetic patients, percentage of depression and sleep 
quality disorders was 78.1, 68, and in non-diabetics, it was 50% and 36%, respectively. This study showed 
significant relationship between sleep quality disorders and depression between the two groups of participants. No 
significant relationship was found regarding control blood sugar, type of treatment and the amount of time a person 
is exposed to the disease and incidence of depression and sleeping problems. Conclusion Regarding the high 
prevalence of depression and sleep disorders in diabetic patients, it is necessary to diagnose depression and sleep 
disorders. 
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Introduction 
Diabetes Mellitus as a non- Contagious chronic 
disease with extensive complication and high prevalence is 
significantly important. Diabetes mellitus type 2 (DMT2) 
Includes a heterogeneous group of disorders characterized by 
varying degrees of insulin resistance, insulin secretion and 
glucose secretion. The global prevalence of diabetes mellitus 
has increased dramatically over the past two decades, from 
around 30 million cases in 1985 to 285 million cases in 2010. 
In 2010, the prevalence of diabetes mellitus in 10 countries 
with the highest prevalence was from 11.6% to 30.9%. 
Glucose tolerance can be evaluated using fasting plasma 
glucose (FPG), oral glucose tolerance test (OGTT) or 
hemoglobin A1C levels (1). Patients with diabetes often have 
other problems. A number of recent studies have reported the 
association of sleep disorder in diabetic patients (2). About 
one third of adults in the world suffer from sleep disorders. 
Also aging and incidence of chronic diseases exacerbate that, 
which increases by as much as 69% (3,4). The prevalence of 
sleep disorders is high in diabetic patients (5). Studies 
mentioned that depth of sleep affects carbohydrate metabolism 
or endocrine system. Insomnia decreases with insulin 
resistance while insulin resistance decreases during sleep. 
These results indicate that sleeplessness and low sleep quality 
is associated with glucose metabolism (6). Depression is the 
most common emotional disorder and the greatest mental 
illness of the present century. Epidemiological evidence 
suggests that at any moment, between 15% and 20% of the 
adult population of the community may exhibit various signs 
and symptoms of severe depression. Depression is one of the 
most common psychiatric disorders in diabetic 
patients .Studies have shown that prevalence of depression in 
diabetic patients is 61.3% (7). Depression significantly 
increases the risk of death among people with diabetes. Sleep 
disorders are associated with depression so that in the absence 
of sleep disorders, the diagnosis of depression is skeptical; 60-
80% of depressed people are afflicted with insomnia 
(8).Diabetics have a shorter sleep time than normal sleep. 
Lack of sleep can have detrimental effects on the health and 
well-being of the patient (9), Therefore, psychological factors 
such as sleep disturbance and depression in these patients 
should be identified and treated. Regarding the prevalence and 
effect of depression and sleep disturbance in diabetic patients 
and its effect on mental health, glucose metabolism and 
prognosis of patients, the present study was conducted to 
compare the frequency of depression and sleep disturbance in 
diabetic patients with non- diabetic patients. 
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Materials and Method 
This cohort study was performed on patients with 
DMT2 who referred to diabetes clinic of 22 Bahman Hospital 
in 2013-2014  in Mashhad, Iran. The diagnosis criteria of 
DMT2 which was done by the American Diabetes Association 
(ADA) are as follows: Fasting Plasma Glucose level≥ 126 
mg / dl, Symptoms of diabetes plus plasma glucose 
concentration≥ 200 mg / dl in randomized samples, or A1C 
hemoglobin ≥ 6.5, or two-hour plasma glucose≥ 200 mg / dl 
during oral glucose tolerance test .The sampling method was 
convenience. 
 After considering the inclusion and exclusion criteria 
the consent of the subjects was taken in writing form.  The 
Pittsburgh sleep quality questionnaire and the checklist 
containing the name, age, sex, height, weight, degree of 
education (cycle-diploma-university) Marital status (single 
married - marriage leading to divorce), number of children, 
duration of diabetes, type of treatment (oral-intestinal), FBS 
and HBA1C were completed by the individual. The nurse 
adjusted the Hamilton Depression questionnaire by 
interviewing the individual. 
 
Eligibility criteria 
The participants of this study were recruited from; 
Patients with DMT2 and healthy subjects over 18 years old; 
who had at least a cycle of education and signed the consent 
form to participate in our study. Exclusion criteria were as 
follows: Patients with DMT2 with severe psychiatric disorders 
such as psychosis; a history of admission to psychiatric section; 
seizure and epilepsy and severe head trauma; and also, who 
taking psychiatric medications currently, severe stress in the 
last six months, night work; excessive alcohol abuse; a history 
of endocrine disorder; history of connective tissue disease; 
pregnant and breastfeeding women and who did not agree to 
participate in this study. 
 
Data collection 
Several methods currently exist for the measurement of 
sleep quality; we used Pittsburgh Sleep Quality Index [PSQI].
(10) This questionnaire is a standard international tool for 
monitoring sleep quality. This index examines attitudes about 
sleep quality over the past four weeks. The questionnaire 
consists of seven sub-indicators including general sleep, sleep 
latency, sleep rate, adequacy of sleep, sleep disorders, 
hypnotics and daily dysfunction. The total score of seven 
scales indicates the total score of individuals' sleep. The 
respondent answers the questions based on their sleep status. 
Then each of the sub-indicators is graded between zero (best 
condition) and three (worst), therefore the total score of the 
questionnaire is between zero and 21 the overall score> 5, 
means poor sleep quality. Many researchers have utilized 
Hamilton questionnaire to measure Depression.(11) This scale 
has 21 items. After an interview with patient, the interviewer 
scores each item on a five-part or three-part scale. The 
Hamilton questionnaire has 21 items of depression and each 
character has three to five options, which range from 0 to 2 or 0 
to 4, graded by severity. The person's score in the Hamilton 
Depression test are divided to 4 ranges which included: 8-13 
(mild depression), 14-18 (moderate depression), 19-22 (severe 
depression) and 23 or more that indicated the severe 
depression. These indexes were selected for their reliability and 
validity. 
 
Statistical analysis 
To evaluate the data, Kolmogorov–Smirnov test   was 
used with Lilliefors correction. Parametric methods such as t
- test and variance analysis were used for normal distribution 
and Spearman correlation, Mann-Whitney and Kruskal-
Wallis tests are used for abnormal distribution. Logistic 
regression was used for results simultaneous analysis. 
Analyses were carried out using IBM-SPSS 20 version and 
the significance of tests considered less than 5%. 
 
Results 
In this study, we conducted 64 patients with type II 
diabetes mellitus (29male (45.3%), 35 female (54.7%)) and 
86 non-diabetic patients (45male (52.3%), 41 female 
(47.7%)).  
The mean depression (14.22±7.94) and mean sleep 
disorder (6.77±3.62) in diabetic patients is significantly 
higher than the control group (8.57±5.54, 4.38±2.32 
respectively). (p<0.05) 
The average rate of depression and sleep disorder in 
diabetic patients who use oral and insulin therapy 
(12.6±8.02, 5.80±2.59 respectively) is lower than the patients 
who use oral (14.20±8.50, 6.85±3.56 respectively) and 
patients who are insulin-dependent (14.68±6.98, 6.84±4.10 
respectively), but this difference is not statistically 
significant. (p>0.05) 
The mean level of depression and sleep disorder in 
diabetic patients with high HBA1C (13.67±7.21, 6.6±3.69 
respectively) is significantly lower than in diabetic patients 
with normal HBA1C (16±9.68, 7.67±3.41 respectively), but 
this difference is not statistically significant. (p>0.05) 
The mean level of depression and sleep disorder in 
diabetic patients with normal FBS (13.2±8.21, 7.05±3.85 
respectively) is significantly lower than diabetic patients with 
abnormal FBS (14.93±7.94, 6.85±3.55 respectively), but this 
difference is not statistically significant. (p>0.05) 
The mean depression and sleep disorder in the 
control group over 50 years was significantly lower in 
diabetic patients over 50 years. (p<0.05) And In control 
group with the age less than 50 years, no significant 
difference was found between the two groups in terms of 
depression. (p>0.05)  
In the male group, the mean of depression and sleep 
disorder in patients (12.38±6.16, 6.03±3.11 respectively) was 
significantly higher than the control group (7.31±3.94, 
4.2±2.12 respectively). (p<0.05) Also in the female group, 
the mean of depression and sleep disorder in patients 
(15.74±8.96, 7.37±3.94 respectively) was significantly 
higher than the control group (9.95±6.66, 4.59±2.54 
respectively). (p<0.05) 
In the group with moderate weights, the mean rate of 
depression was significantly higher in patients (13.47±7.21) 
than in the control group (8.52±5.85). (p<0.05) Also in the 
overweight group, the mean range of depression and sleep 
disorder in patients (14.29±7.87, 7.29±3.62 respectively) was 
significantly higher than the control group (8.54±5.09, 
4.66±1.97 respectively). (p<0.05) and we can consider that 
in the fat group the mean range of sleep disorder in patients 
(6.56±3.67) was significantly higher than the control group 
(3.27±1.35). (p<0.05) 
*Because only one of the controls and patients are 
underweight, so there is no way to test the comparison 
between the two groups. 
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Table 1: Depression and sleep disorder status in diabetics and control group. 
 
 
Table 2: Comparison of depression and sleep disorder in diabetics and control group 
 
 
Table3: Frequency of depression and sleep disorder in diabetic patients, based on a different variables 
 
Variables          Case         Control 
Sleep Disorder 6.77±3.62 4.38±2.32 
Depression 14.22±7.94 8.57±5.54 
Variables   Depression P value Sleep Disorder P value 
  OAD* 14.20±8.50   6.85±3.56   
Type of 
treatment 
Insulin 
OAD + Insulin 
14.68±6.98 
12.60±8.02 
0.876 6.84±4.10 
5.80±2.59 
0.837 
HBA1C Normal 
High 
16.00±9.68 
13.67±7.21 
0.305 7.67±3.41 
6.60±3.69 
0.15 
FBS Normal 
High 
13.20±8.21 
14.93±7.94 
0.414 7.05±3.85 
6.85±3.55 
0.811 
Age*1 ≤50                     Control 
                            Case 
50≤age≤60        Control 
                            Case 
≥60                     Control 
                            Case 
9.04±5.07 
12.07±5.47 
8.75±6.33 
15.88±8.73 
8.15±5.54 
13.76±8.19 
0.085 
  
0.004 
  
0.005 
4.89±2.22 
4.93±1.86 
3.80±1.24 
7.36±3.97 
4.33±2.75 
7.20±3.79 
0.796 
  
0.002 
  
0.001 
Sex Men                    Control 
                            Case 
Women              Control 
                            Case 
7.31±3.94 
12.38±6.16 
9.95±6.66 
15.74±8.96 
0.0001 
  
0.002 
4.20±2.12 
6.03±3.11 
4.59±2.54 
7.37±3.94 
0.01 
  
0.001 
BMI Under weight    Control 
                            Case 
Normal              Control 
                            Case 
Over weight      Control 
                            Case 
Fat                     Control 
                            Case 
4 
11 
8.52±5.85 
13.47±7.21 
8.54±5.09 
14±29±7.87 
9.27±6.69 
15.19±9.40 
  
  
0.009 
  
0.001 
  
0.085 
  
6 
4 
4.48±2.86 
6.21±3.78 
4.66±1.97 
7.29±3.62 
3.27±1.35 
5.56±3.67 
  
  
0.069 
  
0.001 
  
0.004 
  
    Depression Sleep 
Items 
    Non Mild Moderate Severe 
Very 
Severe 
Normal Abnormal 
Duration of 
disease 
      
<10* 23.7 34.2 10.5 15.8 15.8 28.9 71.1 
10<x<20 18.8 37.5 6.20 25.0 12.5 31.2 68.8 
20< 14.3 14.3 28.6 28.6 14.3 28.6 71.4 
Type of 
treatment 
      
OAD*1 22.5 35.0 10.0 17.5 15.0 30.0 70.0 
Insulin 15.8 31.6 15.8 21.1 15.8 31.6 68.4 
OAD ± Insulin 40.0 20.0 0.0 40.0 0.0 40.0 60.0 
HBAIC     
Normal 16.7 33.3 5.6 22.2 22.2 11.1 88.9 
High 23.3 32.6 14.0 18.6 11.6 37.2 62.8 
FBS     
Normal 25.0 35.0 10.0 20.0 10.0 25.0 31.7 
Abnormal 19.5 31.7 12.2 19.5 17.1 75.0 68.3 
Sex 
Men   
Control 55.6 40.0 4.4 0.0 0.0 62.2 37.8 
Case 27.6 41.4 6.9 13.8 10.3 41.4 58.6 
Women   
Control 43.9 29.3 14.6 2.4 9.8 65.9 34.1 
Case 17.1 25.7 14.3 25.7 17.1 22.9 77.1 
BMI 
Under 
Weight   
Control 100 0.0       100 0.0 
Case 0.0 100       0.0 100 
Normal   
Control 54.5 30.3 9.1 0.0 6.1 60.6 39.4 
Case 21.1 42.1 0.0 26.3 10.5 47.4 52.6 
Over 
Weight   
Control 46.3 41.5 7.3 2.4 2.4 61.0 39.0 
Case 25.0 25.0 14.3 28.6 7.1 21.4 78.6 
Fat   
Control 45.5 27.3 18.2 0.0 9.1 81.8 18.2 
Case 18.8 31.2 18.8 0.0 31.2 31.2 68.8 
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Discussion 
In this study we aimed to investigate the 
frequency of depression and sleep disorder and their 
effect on diabetic patients in comparison with non-
diabetics. 
Our study showed higher prevalence of 
depression in diabetic patients than non- diabetics. The 
rate of depression in patients was 78.1%, and in non-
diabetic group was 50%. In this regard, a study that 
conducted by Noroozinejad et al. (12) in 2003 on 309 
diabetic patients in Golestan hospital, Ahwaz, Iran. To 
compare the rate of depression in diabetic patients with 
non -diabetics, in which the frequency of depression in 
the diabetic group (72.2%) was higher than Non-
diabetic group (37%). 
 In our study, the prevalence of depression in both 
sexes in diabetic patients is more than control group. 
The prevalence of depression in diabetic women was 
82.9% and in diabetic men was 72.4%. It didn't 
considered in other studies, so there is no evidence to 
prove or disprove it. 
We found that the frequency of depression does 
not correlate with the duration of disease. In a cross-
sectional study that was done by Mousavi et al. (13) in 
2007 in Shahrood, Iran. 100 diabetic patients were 
observed. He concluded that there was no significant 
relation between the duration of diabetes and 
depression. But in another study, in 2008 in Yazd, Iran. 
Mazlomi et al. (14) reported a significant relation 
between duration of diabetes and depression. Taziki et 
al. (15) in 2001 investigate the association of symptoms 
of depression with diabetes and Wrap up to the same 
result. 
In our study, the frequency of depression in 
diabetic patients older than 50 years is more common 
than non- diabetic group. Taziki et al. (15), Mazlomi et 
al. (14) and Ranjbar et al. (16) in their studies revealed 
that with increasing age, the rate of depression among 
diabetic patients increased significantly. Also, in our 
study, there was no significant relation between the 
prevalence of depression and type of treatment. In 2003, 
in Shiraz, Iran. Ranjbar et al. (16) aimed to compare the 
incidence and severity of depression in adult diabetic 
patients who took pills and insulin and finally achieved 
that there is no significant relation between type of 
treatment and depression that we also achieved the same 
outcome. These results suggest that the type of blood 
glucose regulator does not effect on depression. But this 
is contrary to the achievements of the study that 
conducted by SepehrManesh et al. (17) in 2001 in 
Kashan, Iran, also Noroozinejad et al. (12) concluded 
that depression had been more common in patients who 
use insulin. The difference in the results of studies may 
be due to differences in the participants.  
Our study did not show a significant relation 
between the frequency of depression and blood glucose 
control. In a study that conducted by Parham et al. (18) 
in 2013 in Qom, Iran, and also a study that was done by 
Nejati safa et al. (19) in 2007 in Tehran, Iran, it was 
concluded that there is no significant relation between 
blood glucose control and depression. But Richardson et 
al. (20) designed a retrospective study to investigate the 
effects of depression on glycemic control in patients 
with type 2 diabetes. He showed that the rate of FBS in 
depressed diabetic patients was higher than non-
depressed diabetics. The differences in results could be 
due to the differences in methods, he has been 
examined blood glucose levels in patients who used 
insulin. The cause of higher symptoms of depression in 
patients can be related to the psychological effects of 
using an invasive method, such as insulin injections or 
prolonged duration of the disease.  
Our findings indicate that the prevalence of 
depression in diabetic and overweight individuals is 
higher than non- diabetics. According to recent study 
that was done by Ell et al. (21) in 2015 in America. The 
prevalence of depression in obese diabetic people is 
higher than non- diabetics. This finding is similar to our 
results. 
In our study, the prevalence of sleep disorder in 
diabetic patients was higher than non-diabetic group. 
Hemmati et al. (22) in 2012 designed a study on 180 
patients and Merasi et al. (23) in 2001 that performed a 
case-control study on 834 patients. He considered that 
Sleep disorder was more common in diabetics than non-
diabetic subjects that is similar to our study. 
Our study showed that sleep disorder frequency in 
type 2 diabetic patients is not affected by the duration of 
the disease. In a study conducted by Ozturk et al. (24) in 
2014 in Turkey, 154 patients were diagnosed. He found 
that there was a positive relation between the frequency 
of sleep disorder and the duration of diabetes that is 
similar to our results. 
Our study did not show a positive relation 
between the control of blood glucose and the frequency 
of sleep disorder. Also parallel to our findings, Merasi 
et al. (23) found no relation between FBS level and 
sleep disorder, but there was a significant relationship 
between the increase in HbA1c levels and the increase 
in sleep disorder in his study. 
In a study that conducted by Yi Wen et al. (25) in 
2011 in the United States. There was a direct relation 
between FBS increase and sleep disorder in patients. In 
a study conducted by Tsai et al. (2) in Taiwan in 2009, 
the frequency of sleep disorder has a strong relation 
with poor blood glucose control in diabetic patients. 
According to the differences in results of studies about 
the relation between the blood glucose control and sleep 
disorder in diabetic patients. Perhaps more 
comprehensive studies can provide more accurate 
information on the effect of blood glucose control and 
sleep disorder. 
Our study showed that the frequency of sleep 
disorder in type II diabetic patients is not affected by 
the type of treatment. In the study that conducted by 
Ford et al. (26) There was no significant difference 
between the sleep disorder and type of treatment that is 
similar to our results. 
In our study the frequency of sleep disorder was 
significantly higher in diabetic women than non-
diabetics. Similar to our study, Merasi et al. (23), 
Showed that the frequency of sleep disorder in diabetic 
women is higher. 
The frequency of sleep disorder in diabetic 
patients with overweight and obesity was significantly 
Published online in http://ijam.co.in 
202 
Parisa Ghasemi Noghabi et.al., Frequency of depression and sleep quality in diabetes patients 
ISSN: 0976-5921 
higher than non-diabetics. But in the study that 
performed by Merasi et al. (23), there was no significant 
relation between BMI and sleep status among diabetic 
patients.  
 
Limitations 
In this study, laboratory criteria were not 
measured by the same labs. 
It is recommended that studies be conducted with 
a larger sample size. 
It is suggested that a prospective cohort study is 
conducted to investigate the relation between the 
duration of diabetes and the type of treatment with the 
frequency of depression and sleep disorder in order to 
obtain more accurate and reliable results. 
 
Conclusion 
The results of this study showed that the 
frequency of depression and sleep disorder in diabetic 
patients was higher than non-diabetic subjects. Which 
indicates the importance of paying attention to sleep 
hygiene and the individual's psychological state, 
especially in terms of depression, the patient's training, 
relaxation techniques, screening and timely referral to a 
psychiatrist or psychologist. 
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